| 2024-03-05 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 48,629 0.0043% | $13.52 | $657,240 | +4.29% | |
| 2024-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 33,512 0.003% | $13.34 | $446,960 | +4.95% | |
| 2024-02-28 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 20,599 0.0018% | $13.12 | $270,176 | +7.56% | |
| 2023-03-07 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 54,007 0.0048% | $9.43 | $509,173 | -1.91% | |
| 2023-03-06 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 18,002 0.0016% | $9.93 | $178,776 | -6.56% | |
| 2023-02-28 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 44,252 0.004% | $9.89 | $437,502 | -6.61% | |
| 2022-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 56,832 0.0051% | $7.48 | $425,245 | +19.03% | |
| 2022-02-28 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 41,196 0.0037% | $8.14 | $335,426 | +8.73% | |
| 2022-02-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 26,270 0.0024% | $9.06 | $238,019 | -2.78% | |
| 2021-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 15,026 0.0014% | $10.58 | $159,041 | -10.49% | |
| 2021-03-03 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 1,986 0.0002% | $10.88 | $21,607 | -13.19% | |
| 2021-03-01 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 41,196 0.0019% | $5.43 | $223,507 | -12.91% | |
| 2021-02-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 136,844 0.0124% | $12.72 | $1.74M | -23.97% | |
| 2020-09-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 666 <0.0001% | $8.98 | $5,984 | +14.47% | |
| 2020-03-17 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 1,232 0.0001% | $7.17 | $8,835 | +44.07% | |
| 2020-03-03 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 1,982 0.0002% | $11.77 | $23,320 | -7.72% | |
| 2020-02-10 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 12,398 0.0011% | $12.24 | $151,773 | -16.19% | |
| 2019-09-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 2,352 0.0002% | $7.82 | $18,393 | +30.94% | |
| 2019-09-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 666 <0.0001% | $7.16 | $4,769 | +37.1% | |
| 2019-03-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | Exec. VP, European Commercial | 2,594 0.0002% | $16.64 | $43,176 | -43.45% |